Zdrowie i gospodarka · 26/12/2000

FDA Announces Collection of Information for Adverse Experience Reporting

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to adverse experience reporting for licensed biological products, which has been submitted to the Office of Management and Budget (OMB) for review and clearance.